HRIM vs Mucosal Impedance in GERD Participants

Withdrawn before enrolling · Not applicable

Conditions studied: Gastro-esophageal Reflux Disease (GERD)

In brief

Does baseline impedance measured during the landmark phase of esophageal High resolution impedance manometry HRIM correlates with direct mucosal impedance measurement and discriminates GERD from non GERD patients?

Key facts

Study ID

NCT02812407

Run by

Mayo Clinic

People needed

0

Starts

2016-06-01

Expected to finish

2019-08-01

Last updated by the study team

2020-06-09

Who can join

Age: 18 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Adults ages 18-90
• Patients scheduled for or have completed a HRIM ( within 5 days)
• Patients scheduled for or recently have completed a MII-pH studies ( within 5 days)
• Patients scheduled for EGD

You may not qualify if…

• Technically limited esophageal HRIM or MII-pH study
• Patients with HRIM and MII-pH studies not performed within 5 days of each other
• Patients with EGD not performed within 30 days of HRIM and MII-pH studies
• Medical conditions such as severe heart or lung disease that preclude safe performance of endoscopy
• Inability to read due to: Blindness, cognitive dysfunction, or English language illiteracy

Where it is running

• Mayo Clinic in Rochester — Rochester, Minnesota, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.